Compare · CLGN vs ISRG
CLGN vs ISRG
Side-by-side comparison of CollPlant Biotechnologies Ltd (CLGN) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLGN and ISRG operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $151.15B, about 21723.0x CLGN ($7.0M).
- CLGN has been more active in the news (11 items in the past 4 weeks vs 3 for ISRG).
- ISRG has more recent analyst coverage (25 ratings vs 1 for CLGN).
- Company
- CollPlant Biotechnologies Ltd
- Intuitive Surgical Inc.
- Price
- -
- -
- Market cap
- $7.0M
- $151.15B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 11
- 3
- Recent ratings
- 1
- 25
CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants that are used for the regeneration of breast tissue; injectable implants to promote breast tissue regeneration; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has a co-development agreement with 3D Systems Corporation for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest CLGN
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
Latest ISRG
- SEC Form 4 filed by Intuitive Surgical Inc.
- SEC Form 4 filed by Intuitive Surgical Inc.
- Barclays initiated coverage on Intuitive Surgical with a new price target
- VP Corporate Controller Widman Fredrik exercised 1,089 shares at a strike of $94.52 and sold $407,765 worth of shares (1,089 units at $374.44) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $17,141 worth of shares (48 units at $357.10) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 764 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $24,671 worth of shares (69 units at $357.55) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 812 units (SEC Form 4)
- New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $59,439 worth of shares (154 units at $385.97) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 881 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $90,778 worth of shares (231 units at $392.98) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 1,035 units (SEC Form 4)
- Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen